QTTB Q1 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$123,000

Operating Income

-$15M

Net Income

$1M

EPS (Diluted)

$0.09

QoQ Revenue Growth

+100.0%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$417,000

Balance Sheet

Total Assets

$152M

Total Liabilities

$104M

Stockholders' Equity

$49M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$3M	-100.0%
Gross Profit	-$123,000	$3M	-104.4%
Operating Income	-$15M	-$7M	-101.3%
Net Income	$1M	-$7M	+115.0%